These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7699075)

  • 21. Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans.
    Meyer W; Mitchell TG; Freedman EZ; Vilgalys R
    J Clin Microbiol; 1993 Sep; 31(9):2274-80. PubMed ID: 8408543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey.
    Meyer W; Marszewska K; Amirmostofian M; Igreja RP; Hardtke C; Methling K; Viviani MA; Chindamporn A; Sukroongreung S; John MA; Ellis DH; Sorrell TC
    Electrophoresis; 1999 Jun; 20(8):1790-9. PubMed ID: 10435451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts.
    Chen SC; Currie BJ; Campbell HM; Fisher DA; Pfeiffer TJ; Ellis DH; Sorrell TC
    Trans R Soc Trop Med Hyg; 1997; 91(5):547-50. PubMed ID: 9463664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015.
    Vélez N; Escandón P
    Mem Inst Oswaldo Cruz; 2016 Oct; 111(10):642-648. PubMed ID: 27706379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
    Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil.
    Ferreira-Paim K; Andrade-Silva L; Mora DJ; Pedrosa AL; Rodrigues V; Silva-Vergara ML
    Mycoses; 2011 Sep; 54(5):e294-300. PubMed ID: 20492533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
    Kassi FK; Bellet V; Drakulovski P; Krasteva D; Roger F; Valérie BA; Aboubakar T; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Yavo W; Menan HIE; Bertout S
    J Med Microbiol; 2018 Jan; 67(1):87-96. PubMed ID: 29214970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan.
    Mihara T; Izumikawa K; Kakeya H; Ngamskulrungroj P; Umeyama T; Takazono T; Tashiro M; Nakamura S; Imamura Y; Miyazaki T; Ohno H; Yamamoto Y; Yanagihara K; Miyzaki Y; Kohno S
    Med Mycol; 2013 Apr; 51(3):252-60. PubMed ID: 22901045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the DiversiLab system for tracing the source of the mixed infections caused by Cryptococcus neoformans var. grubii from a patient with systemic lupus erythematosus.
    Dou H; Xu Y; Li T
    Mycoses; 2015 Mar; 58(3):149-59. PubMed ID: 25591136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptococcus neoformans typing by PCR fingerprinting using (GACA)4 primers based on C. neoformans genome project data.
    Cogliati M; Esposto MC; Liberi G; Tortorano AM; Viviani MA
    J Clin Microbiol; 2007 Oct; 45(10):3427-30. PubMed ID: 17670921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
    Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
    Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular typing technics in the epidemiological study of cryptococcosis].
    Cogliati M; Tortorano AM; Viviani MA
    Ann Ig; 1999; 11(6):497-500. PubMed ID: 10596442
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular characterisation of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province, China.
    Wu SY; Lei Y; Kang M; Xiao YL; Chen ZX
    Mycoses; 2015 May; 58(5):280-7. PubMed ID: 25808662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CAP59 gene amplification in Cryptococcus neoformans and Cryptococcus gattii directly from a yeast suspension].
    Siachoque N; Jewtuchowicz VM; Iovannitti C; Mujica MT
    Rev Argent Microbiol; 2010; 42(2):91-4. PubMed ID: 20589327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology and antifungal susceptibility profiles of clinical
    Bandalizadeh Z; Shokohi T; Badali H; Abastabar M; Babamahmoudi F; Davoodi L; Mardani M; Javanian M; Cheraghmakani H; Sepidgar AA; Badiee P; Khodavaisy S; Afshari SAK; Ahmadikia K; Seyedmousavi S
    J Med Microbiol; 2020 Jan; 69(1):72-81. PubMed ID: 31750814
    [No Abstract]   [Full Text] [Related]  

  • 38. Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal.
    Capoor MR; Mandal P; Deb M; Aggarwal P; Banerjee U
    Mycoses; 2008 May; 51(3):258-65. PubMed ID: 18399907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
    Feng X; Yao Z; Ren D; Liao W; Wu J
    FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.
    Viviani MA; Cogliati M; Esposto MC; Lemmer K; Tintelnot K; Colom Valiente MF; Swinne D; Velegraki A; Velho R;
    FEMS Yeast Res; 2006 Jun; 6(4):614-9. PubMed ID: 16696657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.